Skip to main content
. 2015 Dec 7;7(2):1863–1877. doi: 10.18632/oncotarget.6495

Table 2. b-LMB has anti-cancer activity that is less potent than unmodified LMB in a cellular cytotoxicity assay.

Cell Line Selinexor IC50 (nM) LMB IC50 (nM) b-LMB IC50 (nM)
MM.1S 20 0.46 3.1
HCT-116 50 0.19 6.0
AML2 90 0.39 2.53
AML3 270 0.68 4.68